News - Page 214 - Psychedelic Alpha

Introducing The Psychedelic Practitioner, a new publication by Psychedelic Alpha.

Read more about the article UK Regulators Approve Beckley Psytech Study of Psilocybin for Debilitating Headache Condition

UK Regulators Approve Beckley Psytech Study of Psilocybin for Debilitating Headache Condition

Post published:January 27, 2021
Post category:Analysis News

Read more about the article Psyence Group to Commence Trading (CSE:PSYG) on January 27, 2021

Psyence Group to Commence Trading (CSE:PSYG) on January 27, 2021

Post published:January 26, 2021
Post category:Press Release

Read more about the article atai Life Sciences to Collaborate with Massachusetts General Hospital to Accelerate Discovery of Mechanisms Underlying Therapeutic Effects of Psychedelic Agents

atai Life Sciences to Collaborate with Massachusetts General Hospital to Accelerate Discovery of Mechanisms Underlying Therapeutic Effects of Psychedelic Agents

Post published:January 26, 2021
Post category:Press Release

Read more about the article Novamind Announces Marketing Services Agreements

Novamind Announces Marketing Services Agreements

Post published:January 26, 2021
Post category:Press Release

Read more about the article MINDCURE Announces Pre- and Post-Psychedelic Therapy Adaptogen Supplements, Defining New Product Category

MINDCURE Announces Pre- and Post-Psychedelic Therapy Adaptogen Supplements, Defining New Product Category

Post published:January 26, 2021
Post category:Press Release

Read more about the article Silo Pharma Reaches Terms with University of Maryland Baltimore for Exclusive License of Central Nervous Homing Peptide for Neuroinflammatory Disease

Silo Pharma Reaches Terms with University of Maryland Baltimore for Exclusive License of Central Nervous Homing Peptide for Neuroinflammatory Disease

Post published:January 26, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US

Field Trip Health Ltd. Announces Opening of Field Trip Health Center in Atlanta, GA, as it Continues Expansion in the US

Post published:January 26, 2021
Post category:Press Release

Read more about the article Nova Launches Preclinical Autism Spectrum Disorder Therapeutic Study

Nova Launches Preclinical Autism Spectrum Disorder Therapeutic Study

Post published:January 26, 2021
Post category:Press Release

Read more about the article Awakn Appoints James Collins, Ex-Accenture Strategy MD, as Chief Operating Officer

Awakn Appoints James Collins, Ex-Accenture Strategy MD, as Chief Operating Officer

Post published:January 25, 2021
Post category:Press Release

Read more about the article PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer

PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer

Post published:January 25, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.